HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment

HCMV miRNA 对病毒装配室的分泌和形成的调节

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Human cytomegalovirus (HCMV) infection of primary cells results in massive alterations in normal cellular metabolism and regulation of cellular pathways that govern cell death, nucleic acid replication, cellular membrane homeostasis, cytoskeleton integrity, and intracellular trafficking of proteins. Numerous studies have documented the widespread dysregulation of cellular gene transcription following HCMV infection arguing that major changes in cellular phenotypes are controlled at a transcriptional level. However, crude regulation of essential and highly coordinated cellular functions such as protein transport and membrane homeostasis could result in a cellular environment that would also limit the production of infectious virus. Our recent studies have demonstrated that HCMV miRNAs regulate the secretory/endocytic pathway during infection by targeting genes encoding-key components of these pathways, thus providing another layer of HCMV regulation of cellular functions. Regulation of these pathways by HCMV miRNA results in inhibition of the release of pro-inflammatory cytokines and the reorganization of intracellular membranes to facilitate efficient production of infectious virus. In this project, the specific genes in the secretory/endocytic pathway targeted by HCMV miRNAs will be identified by a comprehensive approach combining PAR-CLIP methodology with informatics followed by rigorous validation. Initially, the role of validated miRNA targets in the regulation of trafficking in the endocytic an secretory pathways will be defined, followed by investigation of the role of these miRNA targets in cytokine trafficking and secretion, membrane reorganization, and infectious virus assembly. Validation of the role of these cellular targets of HCMV miRNAs in regulation of the secretory/endocytic pathways of the infected cells and their phenotypic effects on cytokine secretion and virus assembly will be accomplished by engineering recombinant HCMVs expressing specific combinations of shRNAs targeting genes within these pathways. It is anticipated that these studies will elucidate the role of these regulatory RNAs in the outcome of HCMV infection of the cell as well as defining a new and novel mode of regulation of essential cellular pathways leading to a cellular environment optimized for assembly of infectious virions.
 描述(由申请人提供):原代细胞的人巨细胞病毒(HCMV)感染导致正常细胞代谢和细胞途径调节的巨大改变,这些途径控制细胞死亡、核酸复制、细胞膜稳态、细胞骨架完整性和细胞内蛋白质运输许多研究记录了 HCMV 感染后细胞基因转录的广泛失调,认为细胞表型的主要变化是在转录水平上控制的。我们最近的研究表明,HCMV miRNA 通过靶向编码这些途径的关键成分的基因来调节感染过程中的分泌/内吞途径,因此蛋白质运输和膜稳态可能会导致细胞环境受到限制。 HCMV miRNA 对这些途径的调节导致促炎细胞因子的释放和细胞内膜的重组,以促进感染性病毒的有效产生。 HCMV miRNA 靶向的分泌/内吞途径中的基因将通过将 PAR-CLIP 方法与信息学相结合的综合方法进行鉴定,然后进行严格验证。定义,然后研究这些 miRNA 靶标在细胞因子运输和分泌、膜重组和感染性病毒组装中的作用,验证 HCMV miRNA 的这些细胞靶标在调节细胞因子中的作用。受感染细胞的分泌/内吞途径及其对细胞因子分泌和病毒组装的表型影响将通过工程重组 HCMV 来实现,这些重组 HCMV 表达这些途径中靶向基因的 shRNA 的特定组合。预计这些研究将阐明这些调节 RNA 的作用。细胞的 HCMV 感染的结果,以及定义一种新的、新颖的基本细胞途径调节模式,从而产生针对感染性病毒粒子组装而优化的细胞环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Jarvis Britt其他文献

William Jarvis Britt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Jarvis Britt', 18)}}的其他基金

Tegument Envelope Protein Interactions in CMV Envelopment
CMV 包膜中的皮膜包膜蛋白相互作用
  • 批准号:
    10573700
  • 财政年份:
    2022
  • 资助金额:
    $ 77.07万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
  • 批准号:
    10019411
  • 财政年份:
    2019
  • 资助金额:
    $ 77.07万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
  • 批准号:
    10488568
  • 财政年份:
    2019
  • 资助金额:
    $ 77.07万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
  • 批准号:
    10686167
  • 财政年份:
    2019
  • 资助金额:
    $ 77.07万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation (Vision and auditory screening in infants born to women enrolled in ZIP)
CMV 疫苗:再感染和抗原变异(参加 ZIP 的妇女所生婴儿的视力和听觉筛查)
  • 批准号:
    9472616
  • 财政年份:
    2017
  • 资助金额:
    $ 77.07万
  • 项目类别:
Inflammation and Hearing Loss Following Congenital CMV Infection
先天性巨细胞病毒感染后的炎症和听力损失
  • 批准号:
    9759910
  • 财政年份:
    2017
  • 资助金额:
    $ 77.07万
  • 项目类别:
Inflammation and Hearing Loss Following Congenital CMV Infection
先天性巨细胞病毒感染后的炎症和听力损失
  • 批准号:
    10238050
  • 财政年份:
    2017
  • 资助金额:
    $ 77.07万
  • 项目类别:
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment
HCMV miRNA 对病毒装配室的分泌和形成的调节
  • 批准号:
    9883699
  • 财政年份:
    2016
  • 资助金额:
    $ 77.07万
  • 项目类别:
Congenital CMV and CNS Infection Mechanisms of Protective Immunity
先天性巨细胞病毒和中枢神经系统感染的保护性免疫机制
  • 批准号:
    8450754
  • 财政年份:
    2011
  • 资助金额:
    $ 77.07万
  • 项目类别:
Congenital CMV and CNS Infection Mechanisms of Protective Immunity
先天性巨细胞病毒和中枢神经系统感染的保护性免疫机制
  • 批准号:
    10398817
  • 财政年份:
    2011
  • 资助金额:
    $ 77.07万
  • 项目类别:

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 77.07万
  • 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
  • 批准号:
    10725416
  • 财政年份:
    2023
  • 资助金额:
    $ 77.07万
  • 项目类别:
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
通过描绘基因 3 端 DNA 甲基化功能,全面了解癌症的表观遗传脆弱性
  • 批准号:
    10765365
  • 财政年份:
    2023
  • 资助金额:
    $ 77.07万
  • 项目类别:
Small molecule therapeutics for myotonic dystrophy type 1
1 型强直性肌营养不良的小分子疗法
  • 批准号:
    10583984
  • 财政年份:
    2023
  • 资助金额:
    $ 77.07万
  • 项目类别:
Regulation of RNA sensing and viral restriction by RNA structures
RNA 结构对 RNA 传感和病毒限制的调节
  • 批准号:
    10667802
  • 财政年份:
    2023
  • 资助金额:
    $ 77.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了